A Single Centre, Phase I, Randomised, Four-way Crossover Study to Evaluate the Effect of Food on the Pharmacokinetics of a Single Dose of Two Different Formulations of IMG-7289 (Bomedemstat) Administered Orally in Healthy Adult Volunteers
Latest Information Update: 13 Oct 2021
Price :
$35 *
At a glance
- Drugs Bomedemstat (Primary)
- Indications Acute myeloid leukaemia; Myelodysplastic syndromes; Myelofibrosis
- Focus Pharmacokinetics
- 13 Oct 2021 New trial record
- 07 Oct 2021 Accural to date is 8 according to Australian New Zealand Clinical Trials Registry record